Inclusive
7078
Renascience
4889
Chordia Therapeutics
190A
Kufu Company Holdings
4376
Cube
7112
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 74.69%3.26B | 1.90%1.87B | 27.73%1.83B | 155.43%1.43B | -80.18%561M | 233.61%2.83B | -62.55%848.53M | 408.41%2.27B | -47.26%445.64M | 273.13%844.91M |
Net profit before non-cash adjustment | -23.08%1.61B | 1.58%2.1B | 49.17%2.07B | -3.51%1.38B | -28.38%1.44B | 6.94%2B | 62.50%1.87B | -16.48%1.15B | 32.67%1.38B | 44.44%1.04B |
Total adjustment of non-cash items | 149.59%149.23M | -441.08%-300.91M | 298.80%88.22M | 50.12%-44.38M | -370.54%-88.97M | 108.55%32.88M | -7,569.96%-384.63M | -88.49%5.15M | 502.95%44.74M | -38.15%7.42M |
-Depreciation and amortization | 90.89%154.87M | 49.67%81.13M | 38.30%54.21M | -9.49%39.19M | -2.76%43.3M | -37.49%44.53M | -4.52%71.23M | 23.78%74.61M | 3.60%60.27M | -9.83%58.18M |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -58.15%10.13M | 504.17%24.21M |
-Disposal profit | 101.50%4.44M | -6,803.28%-297.19M | -107,525.00%-4.31M | -101.38%-4K | -48.58%290K | --564K | ---- | -5,050.06%-40.63M | ---789K | ---- |
-Other non-cash items | 88.11%-10.09M | -321.42%-84.85M | 145.86%38.32M | 36.96%-83.57M | -985.72%-132.56M | 97.32%-12.21M | -1,481.59%-455.86M | -15.86%-28.82M | 66.82%-24.88M | -70.18%-74.97M |
Changes in working capital | 2,100.69%1.5B | 121.02%67.94M | -448.41%-323.25M | 111.82%92.78M | -198.84%-785.05M | 224.03%794.27M | -157.82%-640.36M | 213.08%1.11B | -382.56%-979.46M | 59.88%-202.97M |
-Change in receivables | -74.38%61.77M | 125.28%241.04M | -212.52%-953.53M | 194.58%847.46M | 198.42%287.69M | 88.64%-292.32M | -343.78%-2.57B | 150.04%1.06B | -289.32%-2.11B | 32.01%-541.75M |
-Change in inventory | 121.36%17.45M | -183.30%-81.7M | 137.95%98.08M | -1,914.70%-258.47M | -136.72%-12.83M | 262.06%34.94M | 26.00%-21.56M | -470.35%-29.13M | 148.36%7.87M | 30.74%-16.26M |
-Change in prepaid assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---3.69M | ---- | ---- |
-Change in payables | 2,473.13%1.41B | -112.57%-59.5M | 198.30%473.47M | 53.83%-481.66M | -199.60%-1.04B | -45.75%1.05B | 2,424.78%1.93B | -92.48%76.47M | 218.37%1.02B | 0.70%319.6M |
-Change in accrued expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 426.00%104.32M | 1,134.53%19.83M |
-Provision for loans, leases and other losses | 112.07%3.85M | -154.32%-31.9M | 503.53%58.73M | 13.20%-14.56M | -492.72%-16.77M | -81.82%4.27M | 177.34%23.49M | --8.47M | ---- | ---- |
-Changes in other current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 267.82%11.85M |
-Changes in other current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -36.78%3.76M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -21.97%-3.81M | -3.13M | 87.24%-1.22M | -2,036.08%-9.59M | -1,182.86%-449K | -35K | ||||
Interest received (cash flow from operating activities) | 1.30%73.98M | 28.97%73.03M | 12.55%56.63M | -15.96%50.31M | 18.53%59.86M | 20.14%50.51M | -5.99%42.04M | -8.47%44.72M | -19.85%48.86M | 29.58%60.96M |
Tax refund paid | 16.81%-589.36M | -35.65%-708.44M | -18.74%-522.24M | 17.28%-439.83M | 24.83%-531.69M | -99.43%-707.27M | 34.06%-354.64M | -17.76%-537.85M | -38.81%-456.72M | -24.54%-329.03M |
Other operating cash inflow (outflow) | 0 | -1K | 0 | 1K | 0 | 0.00%-1K | -1K | 0 | 0 | -1K |
Operating cash flow | 123.05%2.74B | -9.65%1.23B | 30.81%1.36B | 1,066.62%1.04B | -95.90%89.18M | 312.81%2.17B | -70.30%526.34M | 4,595.00%1.77B | -93.46%37.74M | 6,121.86%576.83M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -360.95%-76.82M | 70.50%-16.67M | -266.95%-56.48M | -45.03%-15.39M | -97.36%-10.61M | 96.67%-5.38M | -1,467.06%-161.3M | -177.96%-10.29M | -337.71%-3.7M | 64.06%-846K |
Net intangibles purchase and sale | 57.97%-125.5M | -58.46%-298.59M | -1,390.23%-188.44M | -237.65%-12.65M | 66.95%-3.75M | -739.41%-11.33M | 92.21%-1.35M | -42.52%-17.33M | 12.40%-12.16M | 86.77%-13.88M |
Net business purchase and sale | ---108.5M | --0 | ---- | ---52.93M | ---- | ---- | ---- | ---- | ---- | ---- |
Net investment product transactions | 160.03%999.69M | 175.71%384.46M | 1.84%-507.78M | -3,743.61%-517.31M | 97.38%-13.46M | -205.00%-512.86M | 5,067.90%488.44M | -25.41%-9.83M | -103.50%-7.84M | 285.37%224.19M |
Advance cash and loans provided to other parties | ---24.5M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Repayment of advance payments to other parties and cash income from loans | --24.5M | ---- | ---- | ---- | ---- | 27.67%33.5M | --26.24M | ---- | ---- | ---- |
Net changes in other investments | 33.33%-2K | -200.00%-3K | 0.00%-1K | ---1K | ---- | -54.41%119K | 100.13%261K | -120.01%-200M | 433.17%999.5M | -250.00%-300M |
Investing cash flow | 895.55%688.87M | 109.19%69.2M | -25.81%-752.7M | -2,050.68%-598.28M | 94.39%-27.82M | -240.78%-495.95M | 248.36%352.3M | -124.33%-237.46M | 1,177.72%975.8M | -49.34%-90.54M |
Financing cash flow | ||||||||||
Net common stock issuance | 12.56%-348.92M | -25.24%-399.06M | -243,127.48%-318.63M | -111.29%-131K | ---62K | ---- | ---172K | --0 | --0 | -651,323.14%-788.22M |
Cash dividends paid | 3.35%-494.5M | -18.08%-511.61M | 16.67%-433.29M | 0.00%-519.95M | -9.09%-519.95M | -69.23%-476.62M | 35.00%-281.65M | -67.52%-433.3M | -8.92%-258.66M | 0.00%-237.49M |
Net other fund-raising expenses | ---- | ---1K | ---- | ---1K | ---- | ---- | ---- | ---- | ---- | ---1K |
Financing cash flow | 7.38%-843.42M | -21.11%-910.67M | -44.58%-751.91M | -0.01%-520.08M | -9.10%-520.01M | -69.12%-476.62M | 34.96%-281.82M | -67.52%-433.3M | 74.78%-258.66M | -331.67%-1.03B |
Net cash flow | ||||||||||
Beginning cash position | 4.29%10.01B | -0.75%9.6B | -0.71%9.67B | -4.60%9.74B | 13.07%10.21B | 7.18%9.03B | 14.60%8.43B | 16.24%7.35B | -7.86%6.33B | -4.04%6.87B |
Current changes in cash | 566.80%2.59B | 370.09%388.15M | -84.21%-143.71M | 82.99%-78.01M | -138.21%-458.65M | 101.10%1.2B | -45.81%596.82M | 45.89%1.1B | 239.94%754.88M | -86.67%-539.42M |
Effect of exchange rate changes | 100.15%47.48M | -66.64%23.72M | 727.48%71.11M | 181.04%8.59M | 46.86%-10.6M | -334.91%-19.95M | 130.32%8.49M | -112.63%-28.01M | -1,317,600.00%-13.18M | --1K |
Cash adjustments other than cash changes | 0.00%1K | --1K | ---- | ---- | 0.00%-1K | -150.00%-1K | --2K | ---- | 28,553,700.00%285.54M | --1K |
End cash Position | 26.32%12.65B | 4.29%10.01B | -0.75%9.6B | -0.71%9.67B | -4.60%9.74B | 13.07%10.21B | 7.18%9.03B | 14.60%8.43B | 16.24%7.35B | -7.86%6.33B |
Free cash flow | 177.80%2.54B | -18.07%914.37M | 10.24%1.12B | 1,253.04%1.01B | -96.53%74.82M | 492.84%2.16B | -79.15%363.69M | 7,872.48%1.74B | -96.11%21.88M | 673.51%562.1M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |